How Upstream Bio, Inc. stacks up

UPB · against 208 other Healthcare companies of similar size

Overall

52/ 100

Above the middle of the pack.

Ranked #63 of 209 · scores higher than 68% of peers

Bars: peers in each 10-point band of the overall score

34 peers with an overall score of 50–59, including UPB · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#101 of 209Score 33 / 100 · beats 40%Growth#47 of 178Score 71 / 100 · beats 73%Profitability#201 of 213Score 3 / 100 · beats 4%Risk#1 of 227Lower relative risk · safety 100 · beats 100%

Ranking by overall score

Top 5 and the companies ranked around UPB

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Q32 Bio Inc.QTTB · US-listed	261M USD	97	93	—	98	0 / 2
2	Beijing Chunlizhengda Medical Instruments Co., Ltd.1858.HK · Hong Kong	2.9B HKD (≈$365M)	84	99	63	86	0 / 2
2	Compugen Ltd.CGEN.TA · Middle East	592M ILS (≈$160M)	84	99	99	96	1 / 2
4	Clinuvel Pharmaceuticals LimitedCUV.AX · Australia & NZ	356M AUD (≈$235M)	81	98	35	97	0 / 2
5	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	80	98	35	92	0 / 2
⋯
63	Dentium CO., LTD145720.KS · South Korea	326.5B KRW (≈$235M)	52	87	11	74	1 / 2
63	Yantai Zhenghai Biotechnology Co., Ltd.300653.SZ · China	2.5B CNY (≈$349M)	52	56	18	82	/ 2
63	Peijia Medical Limited9996.HK · Hong Kong	2.4B HKD (≈$310M)	52		86	30	1 / 2
63	LNA Santé SALNA.PA · Europe	251M EUR (≈$276M)	52	92	55	53	2 / 2
63	Upstream Bio, Inc.UPB · US-listed	186M USD	52	33	71	3	0 / 2
69	Medy-Tox Inc.086900.KQ · South Korea	406.2B KRW (≈$292M)	51	61	49	50	1 / 2
69	Qinghai Spring Medicinal Resources Technology Co., Ltd.600381.SS · China	2.4B CNY (≈$331M)	51	0	85	24	0 / 2
69	Organigram Global Inc.OGI · US-listed	133M USD	51	88	—	36	2 / 2
72	PT Lippo Karawaci TbkLPKR.JK · Southeast Asia	2.91T IDR (≈$180M)	50	92	6	45	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…